Douglas Emmett, Inc.: BMO cuts target price to $11 from $13
DEI•BMO cut its price target for Douglas Emmett to $11 from $13.
Related News
Axcelis Technologies target price cut to $165 from $198
ACLS•
Marker Therapeutics awarded $2.6 million FDA grant to advance MT-601 in pancreatic cancer
MRKR•
Analysts revise targets for Analog Devices, IBM and Qualcomm
ADI•
Silgan partners with American Industrial Partners to acquire Trivium
SLGN•
Valero Energy target price raised to $530 from $450
VLO•